Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Impact of Eplerenone on Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetic Patients

Trial Profile

Impact of Eplerenone on Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetic Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2015

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Left ventricular dysfunction
  • Focus Therapeutic Use
  • Sponsors Solvotrin Innovations
  • Most Recent Events

    • 05 Dec 2015 Planned number of patients changed from 30 to 60, according to European Clinical Trials Database record.
    • 05 Dec 2015 Status changed from recruiting to completed, European Clinical Trials Database record.
    • 27 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top